Clinical Trial Update: The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether sublingual nitroglycerin affects absolute coronary blood flow in patients with coronary artery disease and stable angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Angina

Drugs mentioned

• Sublingual nitroglycerin (nitroglycerin)

Snippet

Sponsor: VZW Cardiovascular Research Center Aalst | Conditions: Coronary Arterial Disease (CAD), Angina (Stable) | Phase 4 | Status: COMPLETED